Jonathan Yong
Stock Analyst at UBS
(2.65)
# 3,617
Out of 4,831 analysts
104
Total ratings
60%
Success rate
10.49%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $4.96 | +41.13% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.40 | +17.65% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $16.92 | +35.93% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $22.87 | +9.34% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.37 | +163.85% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $10.47 | +14.61% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.30 | +86.05% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.95 | +86.45% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $64.00 | -78.13% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $70.54 | +36.09% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $15.08 | +112.20% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $21.67 | +384.54% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $117.61 | -31.98% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $250.01 | -7.60% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $94.50 | +6.88% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.62 | +254.33% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $148.26 | -32.55% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $687.78 | -34.57% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.60 | +233.33% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.60 | +821.05% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $14.52 | +17.08% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $310.45 | +12.74% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $26.94 | +252.64% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $8.11 | +4.81% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $24.30 | +68.76% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $7.23 | +135.13% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.80 | +123.68% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $75.82 | +12.11% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $174.49 | -16.33% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $58.97 | +79.75% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $192.17 | -18.30% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $301.89 | +21.90% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $228.89 | +177.43% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $60.50 | +93.39% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.42 | +108.04% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $368.10 | -19.04% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $157.70 | -39.76% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $311.38 | +58.97% | 1 | Oct 15, 2021 |
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $4.96
Upside: +41.13%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.40
Upside: +17.65%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $16.92
Upside: +35.93%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $22.87
Upside: +9.34%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.37
Upside: +163.85%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $10.47
Upside: +14.61%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.30
Upside: +86.05%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.95
Upside: +86.45%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $64.00
Upside: -78.13%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $70.54
Upside: +36.09%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.08
Upside: +112.20%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $21.67
Upside: +384.54%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $117.61
Upside: -31.98%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $250.01
Upside: -7.60%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $94.50
Upside: +6.88%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.62
Upside: +254.33%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $148.26
Upside: -32.55%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $687.78
Upside: -34.57%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.60
Upside: +233.33%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.60
Upside: +821.05%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $14.52
Upside: +17.08%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $310.45
Upside: +12.74%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $26.94
Upside: +252.64%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $8.11
Upside: +4.81%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $24.30
Upside: +68.76%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $7.23
Upside: +135.13%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.80
Upside: +123.68%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $75.82
Upside: +12.11%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $174.49
Upside: -16.33%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $58.97
Upside: +79.75%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $192.17
Upside: -18.30%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $301.89
Upside: +21.90%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $228.89
Upside: +177.43%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $60.50
Upside: +93.39%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.42
Upside: +108.04%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $368.10
Upside: -19.04%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $157.70
Upside: -39.76%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $311.38
Upside: +58.97%